HLA-G gene expression influenced at allelic level in association with end stage renal disease and acute allograft rejection

Human Immunology

Volumn 75, Issue 8, 2014, Pages 833-839

  Misra, Maneesh Kumar ^a,b   Pandey, Shashi Kant ^b   Kapoor, Rakesh ^a   Sharma, Raj Kumar ^a   Kapoor, Rohit ^c   Prakash, Swayam ^a   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c Era's Lucknow Medical College and Hospital   (India)

Author keywords

Acute allograft rejection; End stage renal disease; HLA G allele; HLA G expression; UTR haplotype

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; EVEROLIMUS; HLA G ANTIGEN; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; ISOPROTEIN;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; END STAGE RENAL DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HEMODIALYSIS; HLA G ANTIGEN GENE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROMOTER REGION; UNTRANSLATED REGION; ACUTE DISEASE; ALLOTRANSPLANTATION; CASE CONTROL STUDY; GENE EXPRESSION; GENE FREQUENCY; GENETICS; GRAFT REJECTION; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; PATHOLOGY; RISK; SOLUBILITY;

ACUTE DISEASE; ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GRAFT REJECTION; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RISK; SOLUBILITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84905117921     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.06.005     Document Type: Article

References (37)

1. US Renal Data System: USRDS 2004 Annual Data Report:Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004.
2. Ando M., Shibuya A., Yasuda M., Azuma N., Tsuchiya K., Akiba T., et al. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005, 20:2497-2503.
3. Sester U., Sester M., Hauk M., Kaul H., Kohler H., Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000, 15:1217-1223.
4. Amirzargar A., Lessanpezeshki M., Fathi A., Amirzargar M., Khosravi F., Ansaripour B., et al. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc 2005, 37(7):2985-2987.
5. Donadi E.A., Castelli E.C., Arnaiz-Villena A., Roger M., Rey D., Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68(3):369-395.
6. Menier C., Rouas-Freiss N., Favier B., LeMaoult J., Moreau P., Carosella E.D. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue antigens 2010, 75:201-206.
7. Rajagopalan S., Bryceson Y.T., Kuppusamy S.P., Geraghty D.E., van der Meer A., Joosten I., et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006, 4(1):e9.
8. Moreau P., Mouillot G., Rousseau P., Marcou C., Dausset J., Carosella E.D. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci USA 2003, 100(3):1191-1196.
9. Hviid T.V., Christiansen O.B. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G possible implications for human reproduction and autoimmune disease. Hum Immunol 2005, 66(6):688-699.
10. Berger D.S., Hogge W.A., Barmada M.M., Ferrell R.E. Comprehensive analysis of HLA-G: implications for recurrent spontaneous abortion. Reprod Sci 2010, 17:331-338.
11. Tan Z., Shon A.M., Ober C. Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet 2005, 14:3619-3628.
12. Hviid T.V., Rizzo R., Melchiorri L., Stignani M., Baricordi O.R. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006, 67:53-62.
13. Castelli E.C., Mendes-Junior C.T., Deghaide N.H., de Albuquerque R.S., Muniz Y.C., Simoes R.T., et al. The genetic structure of 3' untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010, 11:134-141.
14. Geraghty D.E., Koller B.H., Orr H.T. A human major histocompatibility complex class I gene that encodes a protein with shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987, 84:9145-9149.
15. Hviid T.V., Hylenious S., Rorbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
16. Ober C., Billstrand C., Kuldanek S., Tan Z. The miscarriage associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006, 21:1743-1748.
17. Solez K., Colvin R.B., Racusen L.C., Haas M., Sis B., Mengel M., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760.
18. Tripathi P., Abbas A., Naik S., Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004, 64:706-710.
19. Akhter A., Das V., Naik S., Faridi R.M., Pandey A., Agrawal S. Up-regulation of HLA-G in JEG-3 cells by dexamethasone and hydrocortisone. Arch Gynecol Obstet 2012, 285:7-14.
20. Li J., Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005, 95:221-227.
21. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003, 100(15):8856-8861.
22. Marchal-Bras-Goncalves R., Rouas-Freiss N., Connan F., Choppin J., Dausset J., Carosella E.D., et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001, 33(3):2355-2359.
23. Gregori S., Tomasoni D., Pacciani V., Scirpoli M., Battaglia M., Magnani C.F., et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010, 116(6):935-944.
24. Kapasi K., Albert S.E., Yie S., Zavazava N., Librach C.L. HLA-G has a concentration dependent effect on the generation of an allo-CTL response. Immunology 2000, 101:191-200.
25. Naji A., Le Rond S., Durrbach A., Krawice-Radanne I., Creput C., Daouya M., et al. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 2007, 110(12):3936-3948.
26. Carosella E.D., Moreau P., Aractingi S., Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001, 22(10):553-555.
27. Fainardi E., Rizzo R., Melchiorri L., Stignani M., Castellazzi M., Caniatti M.L., et al. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2007, 192(1-2):219-225.
28. Qiu J., Terasaki P.I., Miller J., Mizutani K., Cai J., Carosella E.D. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 2006, 6:2152-2156.
29. Pfeiffer K.A., Fimmers R., Engels G., van Der Ven H., van Der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001, 7:373-378.
30. Aldrich C.L., Stephenson M.D., Karrison T., Odem R.R., Branch D.W., Scott J.R., et al. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001, 7:1167-1172.
31. Hviid T.V., Hylenius S., Hoegh A.M., Kruse C., Christiansen O.B. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002, 60:122-132.
32. Rebmann V., van der Ven K., Passler M., Pfeiffer K., Krebs D., Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001, 57:15-21.
33. Castelli E.C., Mendes-Junior C.T., Veiga-Castelli L.C., Roger M., Moreau P., Donadi E.A. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol 2011, 28:3069-3086.
34. Misra M.K., Prakash S., Kapoor R., Pandey S.K., Sharma R.K., Agrawal S. Association of HLA-G promoter and 14 bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. Tissue Antigens 2013, 82(5):317-326.
35. Nicolae D., Cox N.J., Lester L.A., Schneider D., Tan Z., Billstrand C., et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005, 76:349-357.
36. Ober C., Aldrich C.L., Chervoneva I., Billstrand C., Rahimov F., Gray H.L., et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003, 72(6):1425-1435.
37. Hviid T.V., Hylenius S., Lindhard A., Christiansen O.B. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004, 64:66-69.